Investors who lost money on Inspire Medical Systems, Inc.(INSP) should contact The Gross Law Firm about pending Class Action - INSP

Core Viewpoint - Inspire Medical Systems, Inc. is facing allegations of misleading investors regarding the launch of its new product, Inspire V, which reportedly failed due to poor demand and inadequate preparations [1]. Group 1: Allegations and Issues - The complaint states that the launch of Inspire V was a disaster, with significant surplus inventory at providers and reluctance to transition to the new treatment [1]. - Defendants allegedly made false statements assuring investors that all necessary steps for a successful launch were taken, which was later contradicted by the company's failure to complete essential tasks [1]. - Key failures included inadequate training and onboarding for treatment center customers, lack of basic IT systems, and failure to ensure Medicare reimbursement was in place at launch [1]. Group 2: Class Action Details - Shareholders who purchased shares of INSP between August 6, 2024, and August 4, 2025, are encouraged to register for the class action, with a deadline of January 5, 2026, to seek lead plaintiff status [2]. - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].